The number of pharma-Dx partnering agreements is growing by leaps and bounds. Here’s a brief summary of some recent agreements announced by CLP and other news services: Adaptive Biotechnologies According to company sources,...
Read MoreResearchers at the Huntsman Cancer Institute have successfully employed natural language processing software to mine patients’ electronic health records for patterns that could help drive cancer research.
Read More
Examining 12 major types of cancer, scientists at Washington University School of Medicine in St Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body.
Read More
The mutation has been found to play a key role in a variety of cancers, including colorectal cancer (the third leading cause of cancer deaths worldwide), melanoma, papillary thyroid cancer, and hairy cell leukemia.
Read More
Reimbursement looms as major challenge
Read More